GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medistim ASA (OSTO:MEDIO) » Definitions » EV-to-FCF

Medistim ASA (OSTO:MEDIO) EV-to-FCF : 27.17 (As of Apr. 27, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Medistim ASA EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Medistim ASA's Enterprise Value is kr3,075.2 Mil. Medistim ASA's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was kr113.2 Mil. Therefore, Medistim ASA's EV-to-FCF for today is 27.17.

The historical rank and industry rank for Medistim ASA's EV-to-FCF or its related term are showing as below:

OSTO:MEDIO' s EV-to-FCF Range Over the Past 10 Years
Min: 9.59   Med: 32   Max: 94.76
Current: 27.33

During the past 13 years, the highest EV-to-FCF of Medistim ASA was 94.76. The lowest was 9.59. And the median was 32.00.

OSTO:MEDIO's EV-to-FCF is ranked worse than
51.49% of 369 companies
in the Medical Devices & Instruments industry
Industry Median: 26.55 vs OSTO:MEDIO: 27.33

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-04-27), Medistim ASA's stock price is kr171.00. Medistim ASA's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was kr5.670. Therefore, Medistim ASA's PE Ratio for today is 30.16.


Medistim ASA EV-to-FCF Historical Data

The historical data trend for Medistim ASA's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medistim ASA EV-to-FCF Chart

Medistim ASA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 51.97 71.28 56.94 44.26 45.34

Medistim ASA Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 44.26 58.24 52.53 35.32 45.34

Competitive Comparison of Medistim ASA's EV-to-FCF

For the Medical Devices subindustry, Medistim ASA's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medistim ASA's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medistim ASA's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Medistim ASA's EV-to-FCF falls into.



Medistim ASA EV-to-FCF Calculation

Medistim ASA's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=3075.150/113.189
=27.17

Medistim ASA's current Enterprise Value is kr3,075.2 Mil.
Medistim ASA's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr113.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medistim ASA  (OSTO:MEDIO) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Medistim ASA's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=171.00/5.670
=30.16

Medistim ASA's share price for today is kr171.00.
Medistim ASA's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr5.670.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Medistim ASA EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Medistim ASA's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Medistim ASA (OSTO:MEDIO) Business Description

Traded in Other Exchanges
Address
Okernveien 94, Oslo, NOR, 0579
Medistim ASA is a medical device company. It is engaged in researching, developing, producing, distributing and sales of medical equipment through its own business or through participation in other companies, as well related activities. The company's business is focused on cardiac and vascular surgery. The group operates in the USA, Europe, Asia and the Rest of the World. The firm's activity is split into three strategic operating units, Lease of equipment; Lease of equipment and Distribution and sales of third-party products.

Medistim ASA (OSTO:MEDIO) Headlines

No Headlines